In medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed.
In the past most drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new approach has been to understand how disease and infection are controlled at the molecular and physiological level and to target specific entities based on this knowledge.
The process of drug discovery involves the identification of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy. Once a compound has shown its value in these tests, it will begin the process of drug development prior to clinical trials.
More on [ Drug discovery ]

500
Axaron Bioscience AG - A functional genomics company that has emerged from the joint venture BASF-LYNX Bioscience AG. Axaron integrates scientific expertise and technological know-how in the field of functional genomics to provide solutions that increase the quality of life.
Meta Description: [ Axaron is a biotechnology company which pioneers innovative therapies for neurological disorders. Axaron offers partnering opportunities for the biotechnological, pharmaceutical and chemical industry. ]
BlueGnome - Application of advanced statistical methods to the information bottlenecks in drug discovery.
Critical Outcome Technologies - Offers in silico drug discovery service to the pharmaceutical industry. Based in London, Ontario.
Equbits - Offers Support Vector Machine (SVM) modeling packages for high throughput screening for drug development. Located in Palo Alto, California.
Meta Description: [ Provides predictive modeling software designed for challenging problems ]
404
Functional Genetics, Inc. - Functional Genetics is applying gene-inactivation technologies and robust screening methods to discover and validate genes and to develop gene-based pharmaceuticals for human diseases.
Meta Description: [ Functional Genetics is applying gene-inactivation technologies to discover genes and to use its validated genes to develop gene-based pharmaceuticals. ]
GenOdyssee SA - Provides to the pharmaceutical, diagnostic and biotech industry full range of post-genomic services : HT SNP discovery and genotyping, and functional proteomics.
Meta Description: [ Genodysse Pharma build an integrated chain of functional genomic expertises that goes from the characterization of the variability of genes & proteins functions in the worldwide population to the development of innovative drugs and prognostic/diagnostic tools ]
Genomining Virtual Screening Software - Offers software for management of screening pipelines through a batch scheduler system
Genoscience - Uses 3D-structure modeling company in drug development against viruses such as HIV and HCV. Located in Marseille, France.
Meta Description: [ Genoscience is a biopharmaceutical company focus on the development of new drugs against viruses such as Hepatitis C HCV. The company develops three families of compounds: HCV protease inhibitors, HCV fusion inhibitors ]
Quantum Pharmaceuticals - Provides drug discovery using computational technology to simulates intermolecular interactions.
Meta Description: [ Flexible molecular docking software. Drug Discovery virtual screening services. Computational chemistry in-silico tools. Receptor Structure Based Drug design.
Bioinformatics. Drug design computer predictive programs. Post - QSAR Protein-Ligand and Protein-Protein interactions study. Molecular Mo... ]
QuantumLead - offers libraries of compounds ranked by constant affinity to a disease target for drug candidate discovery
Meta Description: [ Docking software, Molecular Modeling, Molecular Simulation, 3d structure based drug design, Post – QSAR Computer Aided Drug Design,
Molecular Docking, Virtual screening, agonist antagonist discovery, protein ligand docking software, ic50,
molecular modeling software and services, pka calcu... ]
Rosetta Inpharmatics - Informational genomics - the integration of bioinformatics with genomics tools to accelerate and improve the drug discovery process. Providing an economical, reliable, and flexible technology for pharmaceutical, biotechnology and agricultural companies.
Meta Description: [ Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery. ]
Structural Genetics - Specializes in proteomics and computational drug discovery designing drug leads using docking and ligand design. Accepts contract projects for lead drug discovery and development of software and databases in proteomics.
Meta Description: [ 6-Jul-04: Structural Genetics ]
| Open Source Drug Discovery for Neglected Diseases | |
| Next Video | |